Grethe Nørskov Rasmussen
Corporate Officer/Principal at FLUOGUIDE A/S
Net worth: 2 M $ as of 30/05/2024
Grethe Nørskov Rasmussen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FLUOGUIDE A/S | Corporate Officer/Principal | 31/12/2018 | - |
Career history of Grethe Nørskov Rasmussen
Former positions of Grethe Nørskov Rasmussen
| Companies | Position | Start | End |
|---|---|---|---|
| ASCENDIS PHARMA A/S | Corporate Officer/Principal | 07/04/2010 | 31/12/2018 |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | 31/12/1999 | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | 31/12/1988 | - |
Training of Grethe Nørskov Rasmussen
| Technical University of Denmark | Doctorate Degree |
Statistics
International
| Denmark | 5 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ASCENDIS PHARMA A/S | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| FLUOGUIDE A/S | Health Technology |
| Private companies | 1 |
|---|---|
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |